flupenthixol has been researched along with Chronic Disease in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (67.74) | 18.7374 |
| 1990's | 5 (16.13) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 1 (3.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Liu, J; Liu, Z; Rong, X; Wang, L; Xiao, S; Zhong, Z | 1 |
| Dose, M; Glaser, T; Lesch, OM; Philipp, M; Schmauss, M | 1 |
| Kissling, W; Lesch, OM; Philipp, M; Ruhrmann, S; Schmauss, M; Seemann, U | 1 |
| Dencker, SJ; Lepp, M; Malm, U | 2 |
| Johnson, DA; Ludlow, JM; Pasterski, G; Street, K; Taylor, RD | 1 |
| Ranta, J; Wistedt, B | 1 |
| Andersen, J; Bjørndal, N; Dencker, SJ; Jørgensen, A; Lundin, L; Malm, U | 1 |
| King, DJ; McDevitt, DG; Salem, SA | 1 |
| Dencker, SJ; Frankenberg, K; Hansen, V; Malm, U | 1 |
| Vichaiya, V | 1 |
| Gerlach, J; Larsen, EB | 1 |
| Freeman, HL | 1 |
| Finkbeiner, T; Glaser, T; Haug, J; Osterheider, M; Pach, J; Tegeler, J | 1 |
| Möller, HJ | 1 |
| Al-Sughayir, MA | 1 |
| Card, IR; Hamilton, M; Mahmoud, MR; Wallis, GG | 1 |
| Bourne, RC; Cotes, PM; Crow, TJ; Ferrier, IN; Johnstone, EC; Owen, F; Robinson, JD | 1 |
| Flanagan, WL; Jorgensen, A; McCreadie, RG; McKnight, J | 1 |
| Bannerjee, A; Ghosh, N; Pinto, R | 1 |
| Banning, B; Freeman, HL; Kelly, HB; Schiff, AA | 1 |
| Kielholz, P; Pöldinger, W; Terzani, S | 1 |
| Angst, J; Margoses, N; Woggon, B | 1 |
| Krska, J; Sampath, G; Shah, A; Soni, SD | 1 |
| Aaes-Jørgensen, T; Gerlach, J; Kistrup, K; Larsen, NE | 1 |
| Ardern, M; Kolakowska, T; Reveley, MA; Williams, AO | 1 |
| Beninger, RJ; Delva, NJ; Ehmann, TS | 1 |
| Cookson, IB | 1 |
| Boddie, HG; Hackett, GI; Harrison, P | 1 |
| Kong, DS; Yeo, SH | 1 |
| Haider, I | 1 |
3 review(s) available for flupenthixol and Chronic Disease
| Article | Year |
|---|---|
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neurologic Examination; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sulpiride; Treatment Outcome | 1997 |
Amisulpride: a review of its efficacy in schizophrenia.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clinical Trials as Topic; Flupenthixol; Haloperidol; Humans; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
[Current status of neuroleptic long term treatment of schizophrenia].
Topics: Ambulatory Care; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Penfluridol; Placebos; Prognosis; Recurrence; Schizophrenia; Tranquilizing Agents | 1975 |
13 trial(s) available for flupenthixol and Chronic Disease
| Article | Year |
|---|---|
Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial.
Topics: Aged; Anthracenes; Antidepressive Agents; Antipsychotic Agents; Anxiety; Chronic Disease; Depression; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2015 |
[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Topics: Antipsychotic Agents; Chronic Disease; Depression; Double-Blind Method; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Data Interpretation, Statistical; Depressive Disorder; Dyskinesia, Drug-Induced; Employment; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Middle Aged; Random Allocation; Recurrence; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Flupenthixol; Humans; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1980 |
[Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
Topics: Adult; Antipsychotic Agents; Chronic Disease; Female; Flupenthixol; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1998 |
A comparative trial of the decanoates of flupenthixol and fluphenazine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Decanoates; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1979 |
High dose flupenthixol decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Flupenthixol; Humans; Middle Aged; Random Allocation; Schizophrenia; Thioxanthenes | 1979 |
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thioxanthenes | 1979 |
Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thioxanthenes | 1987 |
The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1987 |
Chronic muscle contraction headache: the importance of depression and anxiety.
Topics: Adolescent; Adult; Anxiety; Chronic Disease; Clinical Trials as Topic; Depression; Diazepam; Double-Blind Method; Flupenthixol; Headache; Humans; Middle Aged; Muscle Contraction; Random Allocation | 1987 |
Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Female; Flupenthixol; Humans; Length of Stay; Male; Middle Aged; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1985 |
15 other study(ies) available for flupenthixol and Chronic Disease
| Article | Year |
|---|---|
Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Follow-Up Studies; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Social Adjustment; Substance Withdrawal Syndrome; Time Factors | 1980 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1983 |
Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.
Topics: Administration, Oral; Adult; Chronic Disease; Female; Flupenthixol; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Prolactin; Schizophrenia; Thioxanthenes | 1982 |
Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.
Topics: Adult; Aged; Antipyrine; Chronic Disease; Enzyme Induction; Flupenthixol; Half-Life; Humans; Microsomes, Liver; Middle Aged; Schizophrenia; Thioxanthenes | 1982 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Evaluation; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
Blood levels of flupenthixol in patients with acute and chronic schizophrenia.
Topics: Acute Disease; Animals; Chronic Disease; Cross Reactions; Flupenthixol; Humans; In Vitro Techniques; Male; Radioimmunoassay; Radioligand Assay; Rats; Schizophrenia; Thioxanthenes; Time Factors | 1979 |
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Community Mental Health Services; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Thioxanthenes | 1977 |
The long-term treatment of periodical and cyclic depressions with flupenthixol decanoate.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Depression; Female; Flupenthixol; Humans; Male; Periodicity; Thioxanthenes | 1979 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1992 |
Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Male; Middle Aged; Outpatients; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia | 1991 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Prognosis; Schizophrenia | 1986 |
Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |